Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.

Expression of microRNAs in the NCI-60 cancer cell-lines.

Patnaik SK, Dahlgaard J, Mazin W, Kannisto E, Jensen T, Knudsen S, Yendamuri S.

PLoS One. 2012;7(11):e49918. doi: 10.1371/journal.pone.0049918. Epub 2012 Nov 28.

2.

Characterization of microRNA expression levels and their biological correlates in human cancer cell lines.

Gaur A, Jewell DA, Liang Y, Ridzon D, Moore JH, Chen C, Ambros VR, Israel MA.

Cancer Res. 2007 Mar 15;67(6):2456-68.

3.

Global microRNA analysis of the NCI-60 cancer cell panel.

Søkilde R, Kaczkowski B, Podolska A, Cirera S, Gorodkin J, Møller S, Litman T.

Mol Cancer Ther. 2011 Mar;10(3):375-84. doi: 10.1158/1535-7163.MCT-10-0605. Epub 2011 Jan 20.

4.

Characterization of B- and T-lineage acute lymphoblastic leukemia by integrated analysis of MicroRNA and mRNA expression profiles.

Fulci V, Colombo T, Chiaretti S, Messina M, Citarella F, Tavolaro S, Guarini A, Foà R, Macino G.

Genes Chromosomes Cancer. 2009 Dec;48(12):1069-82. doi: 10.1002/gcc.20709.

PMID:
19760605
5.

mRNA and microRNA expression profiles of the NCI-60 integrated with drug activities.

Liu H, D'Andrade P, Fulmer-Smentek S, Lorenzi P, Kohn KW, Weinstein JN, Pommier Y, Reinhold WC.

Mol Cancer Ther. 2010 May;9(5):1080-91. doi: 10.1158/1535-7163.MCT-09-0965. Epub 2010 May 4.

6.

Signatures of microRNAs and selected microRNA target genes in human melanoma.

Philippidou D, Schmitt M, Moser D, Margue C, Nazarov PV, Muller A, Vallar L, Nashan D, Behrmann I, Kreis S.

Cancer Res. 2010 May 15;70(10):4163-73. doi: 10.1158/0008-5472.CAN-09-4512. Epub 2010 May 4.

7.

Hodgkin lymphoma cell lines are characterized by a specific miRNA expression profile.

Gibcus JH, Tan LP, Harms G, Schakel RN, de Jong D, Blokzijl T, Möller P, Poppema S, Kroesen BJ, van den Berg A.

Neoplasia. 2009 Feb;11(2):167-76.

8.

MicroRNA expression profiles for the NCI-60 cancer cell panel.

Blower PE, Verducci JS, Lin S, Zhou J, Chung JH, Dai Z, Liu CG, Reinhold W, Lorenzi PL, Kaldjian EP, Croce CM, Weinstein JN, Sadee W.

Mol Cancer Ther. 2007 May;6(5):1483-91. Epub 2007 May 4.

9.

MicroRNA expression analysis of mammospheres cultured from human breast cancers.

Feifei N, Mingzhi Z, Yanyun Z, Huanle Z, Fang R, Mingzhu H, Mingzhi C, Yafei S, Fengchun Z.

J Cancer Res Clin Oncol. 2012 Nov;138(11):1937-44. doi: 10.1007/s00432-012-1272-5. Epub 2012 Jul 3.

PMID:
22752669
10.

MicroRNA expression profiles in human cancer cells after ionizing radiation.

Niemoeller OM, Niyazi M, Corradini S, Zehentmayr F, Li M, Lauber K, Belka C.

Radiat Oncol. 2011 Mar 31;6:29. doi: 10.1186/1748-717X-6-29.

11.

Transcript and protein expression profiles of the NCI-60 cancer cell panel: an integromic microarray study.

Shankavaram UT, Reinhold WC, Nishizuka S, Major S, Morita D, Chary KK, Reimers MA, Scherf U, Kahn A, Dolginow D, Cossman J, Kaldjian EP, Scudiero DA, Petricoin E, Liotta L, Lee JK, Weinstein JN.

Mol Cancer Ther. 2007 Mar;6(3):820-32. Epub 2007 Mar 5.

12.

Quantitative miRNA expression analysis using fluidigm microfluidics dynamic arrays.

Jang JS, Simon VA, Feddersen RM, Rakhshan F, Schultz DA, Zschunke MA, Lingle WL, Kolbert CP, Jen J.

BMC Genomics. 2011 Mar 9;12:144. doi: 10.1186/1471-2164-12-144.

13.

MicroRNA expression and regulation in human ovarian carcinoma cells by luteinizing hormone.

Cui J, Eldredge JB, Xu Y, Puett D.

PLoS One. 2011;6(7):e21730. doi: 10.1371/journal.pone.0021730. Epub 2011 Jul 12.

14.

RNA helicase DDX5 regulates microRNA expression and contributes to cytoskeletal reorganization in basal breast cancer cells.

Wang D, Huang J, Hu Z.

Mol Cell Proteomics. 2012 Feb;11(2):M111.011932. doi: 10.1074/mcp.M111.011932. Epub 2011 Nov 15.

15.

Identification of a new microRNA expression profile as a potential cancer screening tool.

Roa W, Brunet B, Guo L, Amanie J, Fairchild A, Gabos Z, Nijjar T, Scrimger R, Yee D, Xing J.

Clin Invest Med. 2010 Apr 1;33(2):E124.

PMID:
20370992
16.

Attenuation of the beta-catenin/TCF4 complex in colorectal cancer cells induces several growth-suppressive microRNAs that target cancer promoting genes.

Schepeler T, Holm A, Halvey P, Nordentoft I, Lamy P, Riising EM, Christensen LL, Thorsen K, Liebler DC, Helin K, Ørntoft TF, Andersen CL.

Oncogene. 2012 May 31;31(22):2750-60. doi: 10.1038/onc.2011.453. Epub 2011 Oct 3.

PMID:
21963845
17.

Analysis of the NCI-60 dataset for cancer-related microRNA and mRNA using expression profiles.

Weng CW, Lee SC, Lee YL, Ng KL.

Comput Biol Chem. 2013 Jun;44:15-21. doi: 10.1016/j.compbiolchem.2013.02.001. Epub 2013 Feb 19.

PMID:
23499870
18.

[Potential role of ezrin and its related microRNA in ovarian cancer invasion and metastasis].

Li J, Liang SH, Lu X.

Zhonghua Fu Chan Ke Za Zhi. 2010 Oct;45(10):787-92. Chinese.

PMID:
21176563
19.

Integrated epigenetics of human breast cancer: synoptic investigation of targeted genes, microRNAs and proteins upon demethylation treatment.

Radpour R, Barekati Z, Kohler C, Schumacher MM, Grussenmeyer T, Jenoe P, Hartmann N, Moes S, Letzkus M, Bitzer J, Lefkovits I, Staedtler F, Zhong XY.

PLoS One. 2011;6(11):e27355. doi: 10.1371/journal.pone.0027355. Epub 2011 Nov 4.

20.

Identification of differentially expressed microRNAs in endometrial cancer cells after progesterone treatment.

Bae J, Won M, Kim DY, Kim JH, Kim YM, Kim YT, Nam JH, Suh DS.

Int J Gynecol Cancer. 2012 May;22(4):561-5. doi: 10.1097/IGC.0b013e31824927db.

PMID:
22543862
Items per page

Supplemental Content

Write to the Help Desk